Tag: biomedical
-
Early Results Show Anti-Depressive Drug Effects
Initial results from a clinical trial show a drug designed to supplement first-line treatments helps reduce symptoms of major depressive disorder.
-
Real-World Evidence Assessed for Cancer Drug Trials
Two medical technology companies are evaluating real-world evidence from patients to simulate randomized clinical trials for testing new cancer treatments.
-
Trial to Test CBD for Parkinson’s-Related Psychosis
A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations and delusions among people with Parkinson’s disease.
-
Q3 Venture Investing Falls, Biotech Remains Hot
Venture capital investments fell in the third quarter of 2019, both in dollar volumes and number of deals, with declines occurring in the U.S. and worldwide.
-
Nanoparticles Designed to Cross Blood-Brain Barrier
Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain.
-
NSF Funds Blockchain Health Care Data System
A new grant finances design of a lower-cost health care data network built with blockchain that promises to preserve patients’ security and privacy.
-
A.I. Image Analysis Computes Stroke Damage
A review study shows an analysis of CT scans using artificial intelligence matches calculations of damage from stroke made with more advanced imaging.
-
Companies Developing Hemophilia Gene Editing Therapy
A partnership between drug maker Novo Nordisk and biotechnology company bluebird bio is designing a treatment for hemophilia with gene-editing proteins.
-
Merck Gaining Gut Microbe Technology for Vaccines
Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines.
-
Peanut Allergy Patch Under FDA Review
A device to build a tolerance of peanuts in children with a peanut allergy, worn like a patch on the skin, is under review by the Food and Drug Administration.